355 related articles for article (PubMed ID: 29268595)
1. Microbiota, a key player in alcoholic liver disease.
Cassard AM; Ciocan D
Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
3. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
4. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
5. Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier.
Liu H; Kang X; Yang X; Yang H; Kuang X; Ren P; Yan H; Shen X; Kang Y; Li L; Wang X; Guo L; Tong M; Fan W
Probiotics Antimicrob Proteins; 2023 Feb; 15(1):185-201. PubMed ID: 36456838
[TBL] [Abstract][Full Text] [Related]
6. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
Huang W; Kong D
Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
[TBL] [Abstract][Full Text] [Related]
7. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
[TBL] [Abstract][Full Text] [Related]
8. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-based treatments in alcoholic liver disease.
Sung H; Kim SW; Hong M; Suk KT
World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
[TBL] [Abstract][Full Text] [Related]
10. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
11. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis.
Forsyth CB; Farhadi A; Jakate SM; Tang Y; Shaikh M; Keshavarzian A
Alcohol; 2009 Mar; 43(2):163-72. PubMed ID: 19251117
[TBL] [Abstract][Full Text] [Related]
13. Microbiota, Liver Diseases, and Alcohol.
Cassard AM; Gérard P; Perlemuter G
Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
[TBL] [Abstract][Full Text] [Related]
14. Targeting the gut barrier for the treatment of alcoholic liver disease.
Zhou Z; Zhong W
Liver Res; 2017 Dec; 1(4):197-207. PubMed ID: 30034913
[TBL] [Abstract][Full Text] [Related]
15. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
[TBL] [Abstract][Full Text] [Related]
16. Pectin in Metabolic Liver Disease.
Hu W; Cassard AM; Ciocan D
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615814
[TBL] [Abstract][Full Text] [Related]
17. Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota.
Ran B; Guo CE; Li W; Li W; Wang Q; Qian J; Li H
J Sci Food Agric; 2021 May; 101(7):2846-2854. PubMed ID: 33145761
[TBL] [Abstract][Full Text] [Related]
18. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
Hartmann P; Schnabl B
Semin Liver Dis; 2021 Jan; 41(1):87-102. PubMed ID: 33957682
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Osteopontin Protects From Alcohol-induced Liver Injury by Preserving the Gut Microbiome and the Intestinal Barrier Function.
Das S; Song Z; Han H; Ge X; Desert R; Athavale D; Babu Komakula SS; Magdaleno F; Chen W; Lantvit D; Guzman G; Nieto N
Cell Mol Gastroenterol Hepatol; 2022; 14(4):813-839. PubMed ID: 35811073
[TBL] [Abstract][Full Text] [Related]
20. Gut-Liver-Brain Axis and Alcohol Use Disorder: Treatment Potential of Fecal Microbiota Transplantation.
Wolstenholme JT; Duong NK; Brocato ER; Bajaj JS
Alcohol Res; 2024; 44(1):01. PubMed ID: 38322428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
